FTC sues main pharmacy advantage managers around insulin charges The company brought action in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record price of existence-saving insulin medicines. Elevance lowers guidance on ‘unprecedented’ Medicaid difficulties Executives mentioned the enh... https://buschlightpeachcalories16050.blogs-service.com/61616864/everything-about-healthcare-news